Molecular epidemiology of ampicillin-resistant non-β-lactamase- producing Haemophilus influenzae

Journal of Clinical Microbiology

Volumn 36, Issue 12, 1998, Pages 3629-3635

  Gazagne, Louise ^a   Delmas, Catherine ^a   Bingen, Edouard ^b   Dabernat, Henri ^a  

^a CHU PURPAN   (France)

^b HÔPITAL ROBERT DEBRÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; DNA FRAGMENT;

ADOLESCENT; ADULT; ANTIMICROBIAL ACTIVITY; ARTICLE; CHILD; DNA DETERMINATION; FRANCE; HAEMOPHILUS INFLUENZAE; HUMAN; MAJOR CLINICAL STUDY; PENICILLIN RESISTANCE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RIBOTYPING;

HAEMOPHILUS INFLUENZAE; NEGIBACTERIA;

EID: 0031753481     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.36.12.3629-3635.1998     Document Type: Article

References (38)

1. Barry, A. L., P. C. Fuchs, J. H. Jorgensen, F. C. Tenover, S. D. Allen, D. J. Hardy, and J. C. McLaughlin. 1993. Susceptibility of Haemophilus influenzae to piperacillin-tazobactam combinations: interpretive criteria and quality control limits for standardized tests. J. Clin. Microbiol. 31:751-753.
2. Barry, A. L., P. C. Fuchs, and M. A. Pfaller. 1993. Susceptibilities of β-lactamase-producing and -nonproducing ampicillin-resistant strains of Haemophilus influenzae to ceftibuten, cefaclor, cefuroxime, cefixime, cefotaxime, and amoxicillin-clavulanic acid. Antimicrob. Agents Chemother. 37:14-18.
3. Bell, S. M., and D. Plowman. 1980. Mechanisms of ampicillin resistance in Haemophilus influenzae from respiratory tract. Lancet i:279-280.
4. Bruce, K. D., and J. Z. Jordens. 1991. Characterization of noncapsulate Haemophilus influenzae by whole-cell polypeptide profiles, restriction endonuclease analysis, and rRNA gene restriction patterns. J. Clin. Microbiol. 29: 291-296.
5. Clairoux, N., M. Picard, A. Brochu, N. Rousseau, P. Gourde, D. Beauchamp, T. R. Parr, M. G. Bergeron, and F. Malouin. 1992. Molecular basis of the non-β-lactamase-mediated resistance to β-lactam antibiotics in strains of Haemophilus influenzae isolated in Canada. Antimicrob. Agents Chemother. 36:1504-1513.
6. Collignon, P. J., J. M. Bell, S. J. Macinness, G. L. Gilbert, M. Toohey and The Australian Group for Antimicrobial Resistance (AGAR). 1992. A national collaborative study of resistance to antimicrobial agents in Haemophilus influenzae in Australian hospitals. J. Antimicrob. Chemother. 30:153-163.
7. Dabernat, H. 1991. Centre National de Référence pour Haemophilus influenzae: rapport d'activitiés, année 1990. Bull. Epidemiol. Hebd. 33:140-141.
8. Dabernat, H., C. Delmas. 1996. Activité du Centre National de Référence pour Haemophilus influenzae, bilan 1994-1995. Les débuts de l'après vaccination. Med. Mal. Infect. 26:698-703.
9. Dabernat, H., M. Seguy, and C. Delmas. 1994. Situation en 1993 de la résistance aux antibiotiques chez Haemophilus influenzae en France (bilan du Centre National de Référence pour H. influenzae). Med. Mal. Infect. 24: 1244-1247.
10. Doern, G. V., and R. N. Jones. 1988. Antimicrobial susceptibility testing of Haemophilus influenzae, Branhamella catarrhalis, and Neisseria gonorrhoeae. Antimicrob. Agents Chemother. 32:1747-1753.
11. Doern, G. V., J. H. Jorgensen, C. Thornsberry, D. A. Preston, T. Tubert, J. S. Redding, and L. A. Maher. 1988. National collaborative study of the prevalence of antimicrobial resistance among clinical isolates of Haemophilus influenzae. Antimicrob. Agents Chemother. 32:180-185.
12. Fusté, M. C., M. A. Pineda, J. Palomar, M. Vias, and J. G. Lorén. 1996. Clonality of multidrug-resistant nontypeable strains of Haemophilus influenzae. J. Clin. Microbiol. 34:2760-2765.
13. Gutmann, L., R. Williamson, E. Collatz, and J. F. Acar. 1988. Mechanisms of beta-lactam resistance in Haemophilus influenzae. Eur. J. Clin. Microbiol. Infect. Dis. 7:610-615.
14. Heelan, J. S., D. Chesney, and G. Guadano. 1992. Investigation of ampicillin-intermediate strains of Haemophilus influenzae using the disk procedure and current National Committee for Clinical Laboratory Standards guidelines. J. Clin. Microbiol. 30:1674-1677.
15. Kayser, F. H., G. Morenzoni, and P. Santanam. 1990. The second European collaborative study on the frequency of antimicrobial resistance in Haemophilus influenzae. Eur. J. Clin. Microbiol. Infect. Dis. 9:810-817.
16. 15a. Kilian, M. A. 1976. A taxonomic study of the genus Haemophilus with the proposal of a new species. J. Gen. Microbiol. 93:9-62.
17. Loos, B. G., J. M. Bernstein, D. M. Dryja, T. F. Murphy, and D. P. Dickinson. 1989. Determination of the epidemiology and transmission of nontypeable Haemophilus influenzae in children with otitis media by comparison of total genomic DNA restriction fingerprints. Infect. Immun. 57:2751-2757.
18. Malouin, F., and L. E. Bryan. 1986. Modification of penicillin-binding proteins as mechanisms of β-lactam resistance. Antimicrob. Agents Chemother. 30:1-5.
19. Markowitz, S. M. 1980. Isolation of an ampicillin-resistant, non-β-lactamase-producing strain of Haemophilia influenzae. Antimicrob. Agents Chemother. 17:80-83.
20. Mendelman, P. M. 1992. Targets of the β-lactam antibiotics, penicillin-binding-proteins, in ampicillin-resistant non-β-lactamase-producing Haemophilus influenzae. J. Infect. Dis. 165(Suppl. 1):S107-S109.
21. Mendelman, P. M., D. O. Chaffin, C. Clausen, T. L. Stull, C. Needham, J. D. Williams, and A. L. Smith. 1986. Failure to detect ampicillin-resistant, non-β-lactamase-producing Haemophilus influenzae by standard disk susceptibility testing. Antimicrob. Agents Chemother. 30:274-280.
22. Mendelman, P. M., D. O. Chaffin, and G. Kalaitzoglou. 1990. Penicillin-binding proteins and ampicillin resistance in Haemophilia influenzae. J. Antimicrob. Chemother. 25:525-534.
23. Mendelman, P. M., D. O. Chaffin, L. R. Krilov, G. Kalaitzoglou, D. A. Serfass, O. Önay, E. A. Wiley, G. D. Overtuf, and L. G. Rubin. 1990. Cefuroxime treatment failure of nontypable Haemophilus influenzae meningitis associated with alteration of penicillin-binding proteins. J. Infect. Dis. 162: 1118-1123.
24. Mendelman, P. M., D. O. Chaffin, J. M. Musser, R. De Groot, D. A. Serfass, and R. K. Selander. 1987. Genetic and phenotypic diversity among ampicillin-resistant, non-β-lactamase-producing, nontypeable Haemophilus influenzae isolates. Infect. Immun. 55:2585-2589.
25. Mendelman, P. M., D. O. Chaffin, T. L. Stull, C. E. Rubens, K. D. Mack, and A. L. Smith. 1984. Characterization of non-β-lactamase-mediated ampicillin resistance in Haemophilus influenzae. Antimicrob. Agents Chemother. 26: 235-244.
26. Munoz, R., T. J. Coffey, M. Daniels, C. G. Dowson, G. Laible, J. Casal, R. Hakenbeck, M. Jacobs, J. M. Musser, B. G. Spratt, and A. Tomasz. 1991. Intercontinental spread of a multiresistant clone of serotype 23F Streptococcus pneumoniae. J. Infect. Dis. 164:302-306.
27. Murphy, T. F., K. C. Dudas, J. M. Mylotte, and M. A. Apicella. 1983. A subtyping system for nontypable Haemophilus influenzae based on outer-membrane proteins. J. Infect. Dis. 147:838-846.
28. Offit, P. A., J. M. Campos, and S. A. Plotkin. 1982. Ampicillin-resistant, β-lactamase-negative Haemophilus influenzae type b. Pediatrics 69:230-232.
29. Parr, T. R., and L. E. Bryan. 1984. Mechanism of resistance of an ampicillin-resistant, β-lactamase-negative clinical isolate of Haemophilus influenzae type b to β-lactam antibiotics. Antimicrob. Agents Chemother. 25:747-753.
30. 28a. Picard-Pasquier, N., M. Ouagued, B. Picard, P. Goulet, and R. Krishnamoorthy. 1989. A simple, sensitive method of analyzing bacterial ribosomal DNA polymorphism. Electrophoresis 10:186-189.
31. Powell, M., Y. S. Fah, A. Seymour, M. Yuan, and J. D. Williams. 1990. Antimicrobial resistance in Haemophilus influenzae from England and Scotland in 1991. J. Antimicrob. Chemother. 29:547-554.
32. Powell, M., and D. M. Livermore. 1990. Selection and transformation of non-β-lactamase-mediated insusceptibility to β-lactams in Haemophilus influenzae: lack of cross-resistance between carbapenems and other agents. J. Antimicrob. Chemother. 26:741-747.
33. Reid, A. J., I. N. Simpson, P. H. Harder, and S. G. B. Aymes. 1987. Ampicillin resistance in Haemophilus influenzae: identification of resistance mechanisms. J. Antimicrob. Chemother. 20:645-656.
34. Serfass, D. A., P. M. Mendelman, D. O. Chaffin, C. A. Needham. 1986. Ampicillin resistance and penicillin-binding proteins of Haemophilus influenzae. J. Gen. Microbiol. 132:2855-2861.
35. Thomas, W. J., J. W. Mc Reynolds, C. R. Mock, and D. W. Bailey. 1974. Ampicillin-resistant Haemophilus influenzae meningitis. Lancet i:313.
36. Tremblay, L. D., J. L'Ecuyer, P. Provencher, and M. G. Bergeron. 1990. Susceptibility of Haemophilus influenzae to antimicrobial agents used in Canada. Can. Med. Assoc. J. 143:895-901.
37. Williams, J. D., and F. Moosdeen. 1986. Antibiotic resistance in Haemophilus influenzae: epidemiology, mechanisms, and therapeutic possibilities. Rev. Infect. Dis. 8(Suppl. 5):S555-S561.
38. Woolfrey, B. F., R. T. Lally, and M. N. Ederer. 1987. Evaluation of Haemophilus type b systemic isolates for β-lactamase and non-β-lactamase mediated ampicillin resistance and for susceptibility to other antimicrobial agents. Am. J. Clin. Pathol. 88:361-365.